[Heavy silicone oil (Densiron® 68) in proliferative vitreoretinopathy: 4 years of experience]

Abstract

Method: Prospective observational study including 10 patients (age range: 27-74 years) with recurrent retinal detachment (RD) and proliferative vitreoretinopathy (PVR) and 2.8 mean unsatisfactory previous surgeries. Densiron® was injected in all patients, with surgical retinectomy being required in 70% of them. Minimum follow-up time was 12 months.

Results: The mean length of time before Densiron® withdrawal was 4 months. Three patients (30%) presented with a new RD. The main complication detected was cataract development. No relationship was found between re-detachments and tamponade time, baseline disease or RD evolution time. Densiron® may be a good option in cases of recurrent RD in which previous treatment with scleral buckle, gas and/or 1,000/5,000 silicone oils has proven to be unsatisfactory.

Keywords: Aceite de silicona pesado; Densiron 68; Desprendimiento de retina; Heavy silicone oil; Proliferaciones vitreorretinianas; Proliferative vitreoretinopathy; Retinal detachment; Tamponade; Tamponador.